Comparing Post-Transplant Cyclophosphamide as GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
This randomized clinical trial will evaluate two approaches of GvHD prophylaxis; the standard of care GVHD prophylaxis regimen (methotrexate/calcineurin inhibitors) and post-transplant cyclophosphamide with calcineurin inhibitors for their efficacy as a new GVHD prophylaxis strategy.
Epistemonikos ID: e2998b3c3d50f646f84b17f540f848b8e62d5148
First added on: Jan 21, 2022